Ahmet Hoke, M.D., Ph.D.

Headshot of Ahmet Hoke
  • Director, Neuromuscular Division
  • Professor of Neurology

Languages: English, Turkish


Neurology, Neuropathies

Research Interests

Mechanisms of peripheral neuropathies; developing treatments for nerve regeneration and neuroprotection ...read more

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment


Johns Hopkins Outpatient Center (now called Levi Watkins, Jr., M.D., Outpatient Center)

Appointment Phone: 410-955-2227
601 N. Caroline St.
Baltimore, MD 21287 map
Phone: 410-955-2227


Dr. Ahmet Hoke focuses on neuromuscular diseases with a particular interest in peripheral nerve diseases. He has specialized expertise in nerve conduction studies, electromyography and nerve and muscle biopsy reading. In 2005, he received the coveted Derek Denny Brown Young Neurological Scholar Award given by the American Neurological Association to a member of the association who has achieved a significant stature in neurological research and whose promise of continuing major contributions to the field of neurology is anticipated.

In 2018, Dr. Hoke received the Wolfe Neuropathy Research Prize for the preclinical development of the drug ethoxyquin (EQ-6) for neuroprotection against chemotherapy-induced peripheral neuropathy. The prize was given by the American Neurological Association.

Dr. Ahmet Hoke received his medical degree from Hacettepe University in Ankara, Turkey. He then completed an internship and residency in medicine at MetroHealth Saint Lukes Medical Center in Cleveland, OH. He completed his Ph.D. in Neuroscience at Case Western Reserve University before joining The Johns Hopkins for his neurology residency. He went on to the University of Calgary for a neuromuscular fellowship.

...read more


  • Director, Neuromuscular Division
  • Director, Neuromuscular Pathology Laboratory
  • Professor of Neurology
  • Professor of Neuroscience

Departments / Divisions

Centers & Institutes



  • MD; Hacettepe University (1988)


  • Neurology; Johns Hopkins University School of Medicine (1997)
  • Internal Medicine; Saint Luke's Medical Center (1992)


  • Neuromuscular Medicine; University of Calgary Faculty of Medicine (1999)
  • University of Illinois Urbana-Champaign (1989)

Board Certifications

  • American Board of Psychiatry And Neurology (Neurology) (1999)

Research & Publications

Research Summary

Dr. Hoke's research interest includes studies on basic biology of peripheral axons and Schwann cells and disorders affecting the peripheral nervous system. He uses in vitro and in vivo models of peripheral neuropathies (HIV-associated sensory neuropathies and toxic neuropathies) to study the mechanism of axonal damage and develop therapeutic targets for drug development. In addition, he has other ongoing research focusing on mechanisms of axonal degeneration and regeneration using in vitro and in vivo models.

Activities & Honors


  • Derek Denny Brown Award, American Neurological Association, 2005
  • Clinician Scientist Award, Johns Hopkins University, 2002 - 2004
  • Alberta Heritage Foundation for Medical Research Clinical Research Fellowship, Canada, 1997 - 1999
  • Jay Slotkin Award for Excellence in Research, Johns Hopkins University, USA, 1997
  • Discovery Innovation Award, The Johns Hopkins University School of Medicine, 2017


  • American Academy of Neurology
  • American Association for the Advancement of Science
  • American Neurological Association
  • Peripheral Nerve Society
  • Royal College of Physicians and Surgeons of Canada
  • Society for Neuroscience

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button